A New Chapter in Integrated Cancer Care


Dr. Steven K. Libutti Begins Tenure as New Rutgers Cancer Institute of New Jersey Director and Vice Chancellor for Cancer Programs, Rutgers Biomedical and Health Sciences

Stephen K. Libutti, MD, FACSAiming to further propel scientific discovery as well as augment and expand comprehensive cancer services for patients through collaborative efforts with Rutgers and RWJBarnabas Health, Steven K. Libutti, MD, FACS, began his tenure as the new Director of Rutgers Cancer Institute of New Jersey and Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences at Rutgers University on January 10, 2017. Dr. Libutti is the third permanent director in the 25-year history of Rutgers Cancer Institute of New Jersey. In addition to his leadership roles within Rutgers University, Dr. Libutti also serves as Senior Vice President of Oncology Services for RWJBarnabas Health, further strengthening the university’s partnership with the healthcare system.

Most recently, Dr. Libutti served as Director for the Montefiore Einstein Center for Cancer Care in New York City and was a Professor and Vice Chairman of the Department of Surgery and Professor in the Department of Genetics at Albert Einstein College of Medicine and Montefiore Health System. A surgical oncologist, Dr. Libutti is an internationally known expert in endocrine surgery and the management of neuroendocrine tumors. He is the immediate Past President of the American Association of Endocrine Surgeons. His clinical practice focuses on gastrointestinal malignancies including cancers of the liver and pancreas. The recipient of funding from the National Cancer Institute (NCI) for the past 20 years, Dr. Libutti is also a researcher whose work focuses on developing novel cancer therapies through an understanding of the tumor microenvironment and blood vessel formation in tumors.

Through his vast leadership and oncology expertise, Dr. Libutti will implement a unique vision to position Rutgers Cancer Institute of New Jersey as one of the top National Cancer Institute-designated Comprehensive Cancer Centers in the country as well as expand its impact throughout the RWJBarnabas Health System and the State of New Jersey.  In partnership with RWJBarnabas Health, Dr. Libutti will be recruiting researchers and clinicians to build laboratory sciences, clinical research, and expand cancer services across the RWJBarnabas Health network to meet community and academic needs for inpatient and outpatient activities. 

"As the state’s cancer center, it is part of our mission to advance the understanding of the inner workings of cancer as it is a disease that impacts so many. Cooperative efforts between internationally recognized scientists at Rutgers Cancer Institute of New Jersey, industry, academia and other collaborators will help us further accomplish this goal."

– Stephen K. Libutti, MD, FACS

“I am honored to have been chosen to lead Rutgers Cancer Institute of New Jersey during this pivotal time in its history.  Working closely with my colleagues at Rutgers University, RWJBarnabas Health and community physicians, it will be my privilege to further advance the mission of Rutgers Cancer Institute and Rutgers Biomedical Health Sciences to enhance and expand oncology treatment services for patients,” notes Libutti.

“As the state’s cancer center, it is part of our mission to advance the understanding of the inner workings of cancer as it is a disease that impacts so many. Cooperative efforts between internationally recognized scientists at Rutgers Cancer Institute of New Jersey, industry, academia and other collaborators will help us further accomplish this goal. I look forward to helping spur continued growth in all of these areas in order to further solidify our programs and partnerships as some of the best in the nation, and to improve access and care for our patients,” adds Libutti, who also will have an appointment as a Professor of Surgery at Rutgers Robert Wood Johnson Medical School. 

Dr. Libutti Discusses Advances in Cancer Research and Patient Care on NJTV 

A graduate of Harvard College, Libutti received his MD from the Columbia University College of Physicians and Surgeons.  Following his residency in surgery, he completed a fellowship in Surgical Oncology and Endocrine Surgery in the Surgery Branch of the NCI and was ultimately a tenured Senior Investigator and Chief of the Tumor Angiogenesis Section in the Surgery Branch, NCI. 

The author of more than 270 peer reviewed journal articles, Libutti holds seven U.S. patents, and serves as Editor-in-Chief of Cancer Gene Therapy.  He is the recipient of both NCI and National Institutes of Health Director’s Awards and has been recognized as a top doctor and top cancer doctor by Castle Connelly, as well as one of the best doctors in New York by New York Magazine.  

 

precision medicine at Rutgers Cancer Institute

 

Donate Now

 

 

Proud member of
Big Ten Cancer Research Consortium

 

 

Rutgers Health